Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Results From the Phase III Randomized Trial of Onartuzumab Plus Erlotinib Versus Erlotinib in Previously Treated Stage IIIB or IV Non–Small-Cell Lung Cancer: METLung
PaperCitations, authors & open-access status
Results From the Phase III Randomized Trial of Onartuzumab Plus Erlotinib Versus Erlotinib in Previously Treated Stage IIIB or IV Non–Small-Cell Lung Cancer: METLung is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 328 citations, 2017 year and closed oa status.
328
Citations
2017
Year
closed
OA Status